Teva announces FDA acceptance of sNDA for a higher concentration dose of COPAXONE® given three times a week

Business Wire, 30 May 2013

Accessed on 31 May 2013 from http://www.businesswire.com/news/home/20130530005718/en/Teva-Announces-FDA-Acceptance-sNDA-Higher-Concentration.